Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert J Chilton

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
The Journal of the American Osteopathic Association|June 6, 2002
The new "lower is better" lipid goals: are they achievable with today's drugs?Robert J Chilton
The Journal of the American Osteopathic Association|October 7, 2004
Coadministration therapy in hypercholesterolemia: a novel approach to achieving lipid goals--introductionRobert J Chilton
The Journal of the American Osteopathic Association|July 30, 2003
Lipid and nonlipid benefits of statinsRobert J Chilton
The American Journal of Cardiology|June 14, 2017
IntroductionRobert J Chilton
Diabetes, Obesity & Metabolism|August 14, 2019
Effects of sodium-glucose cotransporter-2 inhibitors on the cardiovascular and renal complications of type 2 diabetesRobert J Chilton
The Journal of the American Osteopathic Association|October 7, 2004
Pathophysiology of coronary heart disease: a brief reviewRobert J Chilton
Diabetes, Obesity & Metabolism|January 19, 2021
Beyond the myocardium: Sodium-glucose co-transporter-2 inhibitors in heart failureRobert J Chilton
Cardiovascular Therapeutics|December 21, 2010
The cardiovascular effects of GLP-1 receptor agonistsTheodore Okerson, Robert J Chilton
Clinical Therapeutics|October 14, 2003
Type 2 diabetes, cardiovascular risk, and the link to insulin resistanceMark W Stolar, Robert J Chilton
Postgraduate Medicine|August 12, 2009
Other important applications for beta-blockers in high-risk patientsBrent M Egan, Robert J Chilton
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
The Journal of the American Osteopathic Association|June 6, 2002
The new "lower is better" lipid goals: are they achievable with today's drugs?Robert J Chilton
The Journal of the American Osteopathic Association|October 7, 2004
Coadministration therapy in hypercholesterolemia: a novel approach to achieving lipid goals--introductionRobert J Chilton
The Journal of the American Osteopathic Association|July 30, 2003
Lipid and nonlipid benefits of statinsRobert J Chilton
The American Journal of Cardiology|June 14, 2017
IntroductionRobert J Chilton
Diabetes, Obesity & Metabolism|August 14, 2019
Effects of sodium-glucose cotransporter-2 inhibitors on the cardiovascular and renal complications of type 2 diabetesRobert J Chilton
The Journal of the American Osteopathic Association|October 7, 2004
Pathophysiology of coronary heart disease: a brief reviewRobert J Chilton
Diabetes, Obesity & Metabolism|January 19, 2021
Beyond the myocardium: Sodium-glucose co-transporter-2 inhibitors in heart failureRobert J Chilton
Cardiovascular Therapeutics|December 21, 2010
The cardiovascular effects of GLP-1 receptor agonistsTheodore Okerson, Robert J Chilton
Clinical Therapeutics|October 14, 2003
Type 2 diabetes, cardiovascular risk, and the link to insulin resistanceMark W Stolar, Robert J Chilton
Postgraduate Medicine|August 12, 2009
Other important applications for beta-blockers in high-risk patientsBrent M Egan, Robert J Chilton
Pageof 5